What drives the recent GV.PA stock volume spike?

The spike reflects thin market cap and episodic orders: GV.PA trades **€0.002** with relative volume **2.71x**. Small trades can move price strongly; news, partnerships, or technical triggers typically amplify volume in micro‑caps.

How does Meyka AI rate GV.PA stock and what does it mean?

Meyka AI gives GV.PA a **58.75** score (Grade C+, HOLD). The grade compares sector and S&P benchmarks, financial growth, metrics and forecasts. It is informational, not investment advice.

What are realistic price targets for GV.PA stock?

Meyka AI's model projects a 12‑month base-case **€0.0045** (approx **150.00%** upside) and a downside stress case near **€0.0010** (approx **-44.44%**). These are model projections and not guarantees.

Should active traders consider GV.PA stock today?

Active traders may find intraday opportunity given **38.49M** volume and high volatility, but should limit size and use strict stop losses due to low market cap, wide spreads and negative fundamentals.

EU Stocks

GV.PA €0.002 pre-market on EURONEXT, 38.49M vol: liquidity watch 13 Jan 2026

ByDanny Kontos January 13, 2026January 13, 2026

GV.PA stock opened pre-market at €0.002 on EURONEXT with heavy trading — 38.49M shares traded versus a 14.22M average. That surge makes Genomic Vision SA (GV.PA) one of today’s most active names in Europe, but liquidity and valuation remain challenges. Volume is driving short-term moves while fundamentals show a small market cap (€693,191.00) and negative EPS. We use Meyka AI’s data to connect trading flow to the company outlook and short-term forecast for active traders and value-focused investors.